We are live on ! Find out more
TARS icon

Tarsus Pharmaceuticals
TARS

40 hedge funds and large institutions have $523M invested in Tarsus Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

62.79% more ownership

Funds ownership: 0% → 62.79% (+63%)

Holders
40
Holders Change
+40
Holders Change %
–
% of All Funds
0.71%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
40
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
+$92.4M
2
RI
RTW Investments
New York
+$70.2M
3
FM
Frazier Management
Washington
+$54.6M
4
CAM
Cormorant Asset Management
Massachusetts
+$48.8M
5
PA
Perceptive Advisors
New York
+$36.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
26
New York State Common Retirement Fund
New York
$145K +$99.7K +3,500 New
MIM
27
MetLife Investment Management
New Jersey
$134K +$92.6K +3,250 New
Wells Fargo
28
Wells Fargo
California
$132K +$91K +3,193 New
MLICM
29
Metropolitan Life Insurance Company (MetLife)
New York
$93.9K +$64.7K +2,271 New
Bank of America
30
Bank of America
North Carolina
$61K +$42.2K +1,483 New
SO
31
STRS Ohio
Ohio
$61K +$42.7K +1,500 New
UBS Group
32
UBS Group
Switzerland
$55K +$37.7K +1,325 New
Citigroup
33
Citigroup
New York
$48K +$32.8K +1,151 New
Bank of Montreal
34
Bank of Montreal
Ontario, Canada
$43K +$27.5K +965 New
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$34K +$23.5K +825 New
Legal & General Group
36
Legal & General Group
United Kingdom
$27K +$18.2K +639 New
TRCT
37
Tower Research Capital (TRC)
New York
$27K +$18.4K +645 New
AIP
38
Ameritas Investment Partners
Nebraska
$21K +$14.7K +515 New
PAM
39
Panagora Asset Management
Massachusetts
$1K +$513 +18 New
AIG
40
American International Group
New York
$148 +$102K +3,574 New
1
2

TARS Hedge Fund Activity: Q4 2020 in Review

40 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Tarsus Pharmaceuticals (TARS) for Q4 2020, worth a combined $523M.

Buyers outnumbered sellers: 40 funds opened new TARS positions and 0 closed out — a net gain of 40 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Vivo Capital, opening a new position worth an estimated $92.4M.

  • 40 institutional investors held Tarsus Pharmaceuticals (TARS) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $523M of Tarsus Pharmaceuticals stock for Q4 2020.
  • 40 funds opened new Tarsus Pharmaceuticals positions in Q4 2020 and 0 closed out, a net change of +40 holders.
  • The largest Tarsus Pharmaceuticals buyer in Q4 2020 was Vivo Capital, an estimated $92.4M added.

Based on aggregated 13F filings for Q4 2020.